Showing results (421-430 of 1,811) with videos related to
Sort By:
Pageof 182
Transplantation and Cellular Therapy|August 7, 2026
The role of physical therapy across the transplant trajectory in allogeneic hematopoietic stem cell transplantation, a systematic review and clinical frameworkHoussem BenJemia, Rebecca Catterina, Maria Laura Calonghi, et al.Transplantation and Cellular Therapy|August 28, 2026
Belumosudil Demonstrates Steroid-Sparing, Safety and Efficacy in Pediatric Chronic Graft Versus Host DiseaseAmitesh Anerao, Joan Morris, Geoffrey Cheng, et al.Transplantation and Cellular Therapy|August 29, 2026
Donor Related Logistical Challenges in Hematopoietic Transplant: A Comparative Analysis of Related and Unrelated DonorsFrederick Ian LeMaistre, Kathryn Yarkony, Alexander J Ambinder, et al.Transplantation and Cellular Therapy|August 27, 2026
Adaptive bridging and holding therapy frequently reduces tumor burden and is associated with reduced toxicity after CAR-T cell therapy in multiple myeloma: A single-center real-world experienceJule Cecilia Artzenroth, Ricardo Kosch, Maximilian Al-Bazaz, et al.Transplantation and Cellular Therapy|August 29, 2026
Letter to the Editor on: "Nosocomial Respiratory Virus Infections in Hematologic Malignancies: Risk Factors for Progression to Lower Respiratory Tract Infection"Xiang Ma, Qingqing ShanTransplantation and Cellular Therapy|August 21, 2026
Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide PatientsCaspian H Oliai, Arpita Gandhi, Rasmus T Hoeg, et al.Transplantation and Cellular Therapy|August 23, 2026
CAR-T and GvHD: Have We Engineered GvHD Out of Allogeneic CAR‑T Therapy?Nabeel Ahmed, Jawaria JabeenTransplantation and Cellular Therapy|September 21, 2026
Risk Factors for Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation Using Rabbit Anti-thymocyte Globulin or Porcine Anti-human T Lymphocyte Immunoglobulin in the Letermovir EraXinyi Jiang, Yifan Yao, Xiaoyan Zhao, et al.Transplantation and Cellular Therapy|September 21, 2026
Early prophylactic rituximab reduces EBV infection and PTLD in high-risk patients receiving allogeneic hematopoietic stem cell transplantationAo Zhang, Zilu Zhang, Haoxing Bian, et al.Transplantation and Cellular Therapy|September 9, 2026
Barriers to Patient Referral and Completion of CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell LymphomaMazyar Shadman, Jenny Ahlstrom, Meghan Gutierrez, et al.Pageof 182